GSE135487
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia
neuroblastoma cells derived from PDOX models were treated with the HIF2A inhibitor in normoxic and hypoxic conditions. Overall design: 3 repetitions of control (DMSO) and PT2385 treated cells +/- hypoxa were harvest and submitted for RNAseq analysis